Iambic Therapeutics: Funding, Investors & Team (Oct 2026)
Iambic Therapeutics is revolutionizing the healthcare industry with its innovative AI-powered drug discovery platform. With a team of top-notch AI specialists and drug discovery professionals, Iambic has a proven track record of quickly delivering effective therapeutics to the clinic. They are currently developing a pipeline of clinical assets to tackle urgent patient needs. To learn more about Iambic, visit their website at iambic.ai.
Iambic Therapeutics has raised $227M across 3 funding rounds on record, the most recent an undisclosed round of $100M announced in Nov 2025.
That round is above the $6.0M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Iambic Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Iambic Therapeutics Funding Rounds
Iambic Therapeutics raised $100M in a Series B announced in Oct 2023.
6 months later, an undisclosed round of $26.9M was announced in Apr 2024.
1.6 years later, an undisclosed round of $100M was announced in Nov 2025.
Iambic Therapeutics Founders and Leadership Team
Contact details for the Iambic Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Iambic Therapeutics Funding Compared to Other Artificial Intelligence Startups
Iambic Therapeutics' latest round of $100M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Iambic Therapeutics in Artificial Intelligence and San Diego
Companies Similar to Iambic Therapeutics
Sirona Medical Inc. is addressing the needs of today’s radiology practices with a novel cloud-native platform…
Leading health plans, program providers, and over 100 communities across the U.S., rely on CredibleMind to…
RapidCanvas is an AI platform that combines the precision and automation of AI agents with the deep domain…
Labelbox is a collaborative data training platform that creates and manages labeled data for machine learning…
Clueso is an AI-driven support system for SaaS applications.
Dapta is a software-as-a-service company that provides a platform with minimal coding required to create APIs…
Factored was co-founded with renowned AI expert Andrew Ng (Stanford/AI Fund/Google Brain/Coursera) and…
Developer of a portable, point-of-care hemodynamic measurement platform that uses proprietary sensor…
Lightsprint provides an AI-native product development platform that supports collaborative software…
Suki is a leading technology company that provides AI-powered voice solutions for healthcare. Its mission is…
Drylab is an AI-powered bioinformatics platform for biomedical data analysis, research workflows, and…
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Iambic Therapeutics Funding FAQs
What does Iambic Therapeutics do?
Iambic Therapeutics is revolutionizing the healthcare industry with its innovative AI-powered drug discovery platform. With a team of top-notch AI specialists and drug discovery professionals, Iambic has a proven track record of quickly delivering effective therapeutics to the clinic. They are currently developing a pipeline of clinical assets to tackle urgent patient needs. To learn more about Iambic, visit their website at iambic.ai.
How much funding has Iambic Therapeutics raised?
Iambic Therapeutics has raised $227M across 3 rounds on record. The most recent is an undisclosed round of $100M announced in Nov 2025.
When did Iambic Therapeutics last raise funding?
Iambic Therapeutics' most recent funding round on record is an undisclosed round of $100M, announced in Nov 2025.
Who founded Iambic Therapeutics?
FundedIQ lists Thomas Miller (Founder) at Iambic Therapeutics.
Where is Iambic Therapeutics headquartered?
Iambic Therapeutics is based in San Diego, California, United States.
How many employees does Iambic Therapeutics have?
Iambic Therapeutics is in the 51-100 employee band.
How does Iambic Therapeutics' funding compare to other Artificial Intelligence startups?
Iambic Therapeutics' latest round of $100M is above the $6.0M median round size for Artificial Intelligence companies on FundedIQ across 7,243 tracked companies over the last two years.
About FundedIQ's Iambic Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Iambic Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.